Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

467.92  +5.89 (+1.27%)

After market: 468.02 +0.1 (+0.02%)

Fundamental Rating

5

Overall CRWD gets a fundamental rating of 5 out of 10. We evaluated CRWD against 282 industry peers in the Software industry. CRWD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CRWD is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
In the past year CRWD had a positive cash flow from operations.
In the past 5 years CRWD reported 4 times negative net income.
CRWD had a positive operating cash flow in each of the past 5 years.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD has a Return On Assets (-1.98%) which is comparable to the rest of the industry.
With a Return On Equity value of -4.99%, CRWD perfoms like the industry average, outperforming 57.45% of the companies in the same industry.
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a better Gross Margin (74.48%) than 64.89% of its industry peers.
In the last couple of years the Gross Margin of CRWD has remained more or less at the same level.
CRWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRWD has more shares outstanding
Compared to 5 years ago, CRWD has more shares outstanding
CRWD has a better debt/assets ratio than last year.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 13.87 indicates that CRWD is not in any danger for bankruptcy at the moment.
CRWD has a better Altman-Z score (13.87) than 90.07% of its industry peers.
The Debt to FCF ratio of CRWD is 0.73, which is an excellent value as it means it would take CRWD, only 0.73 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRWD (0.73) is better than 75.53% of its industry peers.
CRWD has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.22, CRWD perfoms like the industry average, outperforming 45.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Altman-Z 13.87
ROIC/WACCN/A
WACC11.04%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.85 indicates that CRWD should not have too much problems paying its short term obligations.
CRWD has a Current ratio (1.85) which is in line with its industry peers.
CRWD has a Quick Ratio of 1.85. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD's Quick ratio of 1.85 is in line compared to the rest of the industry. CRWD outperforms 57.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.43%, which is quite good.
CRWD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 79.46% yearly.
Looking at the last year, CRWD shows a very strong growth in Revenue. The Revenue has grown by 25.94%.
The Revenue has been growing by 52.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%

3.2 Future

CRWD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.66% yearly.
Based on estimates for the next years, CRWD will show a very strong growth in Revenue. The Revenue will grow by 22.08% on average per year.
EPS Next Y-8.77%
EPS Next 2Y10.63%
EPS Next 3Y17.71%
EPS Next 5Y17.66%
Revenue Next Year21.71%
Revenue Next 2Y21.78%
Revenue Next 3Y22.23%
Revenue Next 5Y22.08%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

CRWD is valuated quite expensively with a Price/Earnings ratio of 125.45.
Compared to the rest of the industry, the Price/Earnings ratio of CRWD is on the same level as its industry peers.
CRWD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.04.
Based on the Price/Forward Earnings ratio of 97.28, the valuation of CRWD can be described as expensive.
CRWD's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.64. CRWD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 125.45
Fwd PE 97.28
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CRWD's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRWD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 113.7
EV/EBITDA 4621.66
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CRWD's earnings are expected to grow with 17.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.63%
EPS Next 3Y17.71%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (7/25/2025, 8:00:00 PM)

After market: 468.02 +0.1 (+0.02%)

467.92

+5.89 (+1.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners73.11%
Inst Owner Change-0.28%
Ins Owners3.08%
Ins Owner Change2.67%
Market Cap116.63B
Analysts76.67
Price Target479.06 (2.38%)
Short Float %3.38%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.96%
Min EPS beat(2)9.3%
Max EPS beat(2)18.62%
EPS beat(4)4
Avg EPS beat(4)11.48%
Min EPS beat(4)5.05%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)12.45%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)21.52%
Revenue beat(2)1
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.53%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.32%
Revenue beat(16)8
Avg Revenue beat(16)0.45%
PT rev (1m)0.96%
PT rev (3m)16.7%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)2.9%
EPS NY rev (1m)0.02%
EPS NY rev (3m)2.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 125.45
Fwd PE 97.28
P/S 28.2
P/FCF 113.7
P/OCF 84.35
P/B 33.8
P/tB 48.35
EV/EBITDA 4621.66
EPS(TTM)3.73
EY0.8%
EPS(NY)4.81
Fwd EY1.03%
FCF(TTM)4.12
FCFY0.88%
OCF(TTM)5.55
OCFY1.19%
SpS16.59
BVpS13.85
TBVpS9.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.48%
FCFM 24.8%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Debt/EBITDA 30.51
Cap/Depr 155.6%
Cap/Sales 8.63%
Interest Coverage N/A
Cash Conversion 5666.88%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 13.87
F-Score4
WACC11.04%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
EPS Next Y-8.77%
EPS Next 2Y10.63%
EPS Next 3Y17.71%
EPS Next 5Y17.66%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%
Revenue Next Year21.71%
Revenue Next 2Y21.78%
Revenue Next 3Y22.23%
Revenue Next 5Y22.08%
EBIT growth 1Y-861.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.18%
EBIT Next 3Y37.44%
EBIT Next 5Y36.81%
FCF growth 1Y37.6%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y34.63%
OCF growth 3Y33.96%
OCF growth 5Y69.1%